ImpediMed Limited
IPDQF
$0.0445
$0.004812.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.52% | -0.23% | -10.67% | -9.69% | -7.86% |
| Total Other Revenue | -348.85% | -360.00% | -150.00% | -62.89% | -63.22% |
| Total Revenue | 9.25% | -0.75% | -11.37% | -10.59% | -8.98% |
| Cost of Revenue | 1.46% | -7.75% | -17.19% | -21.53% | -24.67% |
| Gross Profit | 10.42% | 0.32% | -10.46% | -8.71% | -6.04% |
| SG&A Expenses | -3.94% | 0.16% | 2.90% | 0.18% | -1.67% |
| Depreciation & Amortization | 32.30% | 11.51% | -11.08% | -14.52% | -16.79% |
| Other Operating Expenses | 26.02% | -2.36% | -22.16% | -23.00% | -22.79% |
| Total Operating Expenses | 1.51% | -0.38% | -3.70% | -6.53% | -8.48% |
| Operating Income | 2.02% | 0.21% | -0.12% | 4.59% | 8.25% |
| Income Before Tax | -8.47% | -1.77% | 6.05% | 10.90% | 14.65% |
| Income Tax Expenses | -13.59% | -3.59% | 3.35% | -28.06% | -47.28% |
| Earnings from Continuing Operations | -8.44% | -1.76% | 6.04% | 10.93% | 14.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.44% | -1.76% | 6.04% | 10.93% | 14.73% |
| EBIT | 2.02% | 0.21% | -0.12% | 4.59% | 8.25% |
| EBITDA | 7.08% | 2.74% | -0.23% | 5.06% | 9.81% |
| EPS Basic | 11.11% | 42.86% | 58.44% | 58.02% | 57.65% |
| Normalized Basic EPS | 9.09% | 41.18% | 57.45% | 58.00% | 58.49% |
| EPS Diluted | 11.11% | 42.86% | 58.44% | 58.02% | 57.65% |
| Normalized Diluted EPS | 9.09% | 41.18% | 57.45% | 58.00% | 58.49% |
| Average Basic Shares Outstanding | 0.16% | 99.81% | 56,067.15% | 56,408.38% | 56,753.82% |
| Average Diluted Shares Outstanding | 0.16% | 99.81% | 56,067.15% | 56,408.38% | 56,753.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
